Mechanism of diastolic stiffening of the failing myocardium and its prevention by angiotensin receptor and calcium channel blockers.
about
Inhibition of mineralocorticoid receptor is a renoprotective effect of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor pitavastatin.Increased Circulating Cathepsin K in Patients with Chronic Heart FailureAngiotensin type 1 receptor blocker reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient miceCysteinyl cathepsins: multifunctional enzymes in cardiovascular disease.Cardioprotective mechanisms of lifestyle modifications and pharmacotherapies on cardiac remodeling and dysfunction in hypertensive heart disease: an overview.Cathepsin S-mediated fibroblast trans-differentiation contributes to left ventricular remodelling after myocardial infarction.Mechanisms with clinical implications for atrial fibrillation-associated remodeling: cathepsin K expression, regulation, and therapeutic target and biomarker.NADPH oxidases and cardiac remodelling.Differential Effects in Cardiovascular Markers between High-Dose Angiotensin II Receptor Blocker Monotherapy and Combination Therapy of ARB with Calcium Channel Blocker in Hypertension (DEAR Trial).Azelnidipine, Not Amlodipine, Induces Secretion of Vascular Endothelial Growth Factor From Smooth Muscle Cells and Promotes Endothelial Tube Formation.Ca(2+) channel blocker benidipine promotes coronary angiogenesis and reduces both left-ventricular diastolic stiffness and mortality in hypertensive rats.Pulmonary oxidative stress, inflammation, and dysregulated iron homeostasis in rat models of cardiovascular disease.Inhibition of late Na+ current, a novel target to improve diastolic function and electrical abnormalities in Dahl salt-sensitive rats.
P2860
Q34759691-BA2948A2-9FE0-4D58-BE6C-2C3FF71084EEQ35753850-B9A4382A-6968-457A-90DE-BB543BC7A25AQ35870375-80520227-CB14-4928-88EB-70C91F05AB6AQ36211889-F9E01C7F-F650-404E-8066-389717DB38ACQ36797035-32BF923D-DEC6-4F4E-87E7-5C38CA1DA5F8Q37187482-1275AC13-3680-494B-829D-5C7D500FA900Q37457719-3FD34AB9-21AA-46CA-B279-C271AB9205D0Q37775558-8A6C132A-656A-48F0-892F-F581A0B4E2F0Q39729039-9444B28D-6763-4B50-926F-A813A1A1D72DQ41982703-10501BBE-CF61-4839-BCF2-1F21A80FA5EAQ42709938-CA6CBDB9-3859-497B-B709-7D37EAB58D0EQ43100126-68DA9731-6237-44D7-B3E6-E62DE9D10165Q46828509-EEB7CFB1-1A81-45A4-AD54-AF6B243AC60C
P2860
Mechanism of diastolic stiffening of the failing myocardium and its prevention by angiotensin receptor and calcium channel blockers.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Mechanism of diastolic stiffen ...... and calcium channel blockers.
@ast
Mechanism of diastolic stiffen ...... and calcium channel blockers.
@en
type
label
Mechanism of diastolic stiffen ...... and calcium channel blockers.
@ast
Mechanism of diastolic stiffen ...... and calcium channel blockers.
@en
prefLabel
Mechanism of diastolic stiffen ...... and calcium channel blockers.
@ast
Mechanism of diastolic stiffen ...... and calcium channel blockers.
@en
P2093
P2860
P1476
Mechanism of diastolic stiffen ...... and calcium channel blockers.
@en
P2093
Aiko Inoue
Akihiro Hirashiki
Guo-Ping Shi
Kazumasa Unno
Ken Harada
Kenji Okumura
Kohzo Nagata
Koji Obata
Kyosuke Takeshita
Masafumi Kuzuya
P2860
P356
10.1097/FJC.0B013E3181AB371D
P577
2009-07-01T00:00:00Z